SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 18, 2015. The report details the consummation of a third closing under a Unit Purchase Agreement dated October 23, 2015, involving the sale of unregistered equity securities to accredited investors.
Key Financial Metrics
- Transaction Proceeds (Third Closing): $565,000.50
- Units Issued (Third Closing): 376,667 units
- Unit Composition: 1 share of Common Stock + 1 warrant to purchase 0.5 shares
- Warrant Exercise Price: $1.95 per share
- Total Proceeds (All Closings): $1,020,000.50 (including prior closings of $455,000)
- Total Units Issued (All Closings): 680,000.33 units (303,333.33 prior + 376,667 current)
- Revenue, Profit, Cash Flow, Debt, Liquidity: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the increase in outstanding equity and cash reserves resulting from the third closing. The company raised an additional $565,000.50, bringing the total capital raised under the Purchase Agreement to over $1 million. This represents a significant increase in the number of shares and warrants outstanding compared to the prior period.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the securities were sold unregistered. The transaction relied on exemptions under Section 4(a)(2) and Regulation D (Rule 506) of the Securities Act of 1933. Investors are reminded that the summaries of the Purchase Agreement and Registration Rights Agreement are qualified by reference to the full text of the agreements filed as exhibits.
Investor Verification Checklist
- Verify the total number of outstanding shares and warrants post-transaction.
- Confirm the dilution impact of the 376,667 new units on existing shareholders.
- Review the full text of the Registration Rights Agreement to understand future liquidity options for investors.
- Check subsequent filings for the use of the $1,020,000.50 in raised capital.
- Confirm the company's current cash position and runway, as this filing does not disclose liquidity status.